Results 11 to 20 of about 38,037 (258)

Activation mechanism of PINK1 [PDF]

open access: yesNature, 2021
Mutations in the protein kinase PINK1 lead to defects in mitophagy and cause autosomal recessive early onset Parkinson's disease1,2. PINK1 has many unique features that enable it to phosphorylate ubiquitin and the ubiquitin-like domain of Parkin3-9.
Zhong Yan Gan   +2 more
exaly   +4 more sources

Regulation of mitochondrial permeability transition pore by PINK1 [PDF]

open access: yesMolecular Neurodegeneration, 2012
Background: Loss-of-function mutations in PTEN-induced kinase 1 (PINK1) have been linked to familial Parkinson’s disease, but the underlying pathogenic mechanism remains unclear.
Caballero, Erica   +7 more
core   +7 more sources

Basal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demand [PDF]

open access: yesCell Metabolism, 2018
Dysregulated mitophagy has been linked to Parkinson’s disease (PD) due to the role of PTEN-induced kinase 1 (PINK1) in mediating depolarization-induced mitophagy in vitro.
Thomas G McWilliams   +2 more
exaly   +6 more sources

Mechanism of parkin activation by PINK1 [PDF]

open access: yesNature, 2018
Mutations in the E3 ubiquitin ligase parkin (PARK2, also known as PRKN) and the protein kinase PINK1 (also known as PARK6) are linked to autosomal-recessive juvenile parkinsonism (AR-JP)1,2; at the cellular level, these mutations cause defects in mitophagy, the process that organizes the destruction of damaged mitochondria3,4.
David Komander
exaly   +3 more sources

PINK1-Parkin Pathway Activity Is Regulated by Degradation of PINK1 in the Mitochondrial Matrix

open access: yesPLoS Genetics, 2014
Loss-of-function mutations in PINK1, which encodes a mitochondrially targeted serine/threonine kinase, result in an early-onset heritable form of Parkinson's disease. Previous work has shown that PINK1 is constitutively degraded in healthy cells, but selectively accumulates on the surface of depolarized mitochondria, thereby initiating their autophagic
Ruth E Thomas   +4 more
openaire   +4 more sources

PINK1 signalling in neurodegenerative disease [PDF]

open access: yesEssays in Biochemistry, 2021
Abstract PTEN-induced kinase 1 (PINK1) impacts cell health and human pathology through diverse pathways. The strict processing of full-length PINK1 on the outer mitochondrial membrane populates a cytoplasmic pool of cleaved PINK1 (cPINK1) that is constitutively degraded.
Whiten, Daniel R   +2 more
openaire   +2 more sources

Expression and Significance of Mitochondrial Autophagy-associated Protein PINK1 and Parkin in Parotid Pleomorphic Adenoma and Carcinoma ex Pleomorphic Adenoma

open access: yesZhongliu Fangzhi Yanjiu, 2021
Objective To investigate the expression of mitochondrial autophagy-associated protein PINK1 and Parkin in parotid pleomorphic adenoma (PA) and carcinoma ex pleomorphic adenoma(CA-EX-PA).
DING Gaofeng   +3 more
doaj   +1 more source

MiRNA-1976 Regulates the Apoptosis of Dopaminergic Neurons by Targeting the PINK1 Gene

open access: yesJournal of Integrative Neuroscience, 2023
Introduction: Parkinson’s disease (PD), which is a neurodegenerative disease, requires urgently needed biomarkers to explore its mechanism. We screened for differences in the expression of microRNAs (miRNAs) and identified miR-1976 as a possible ...
Feng Qiu   +5 more
doaj   +1 more source

MitoSwap – Mitophagy partnered with compensatory mitochondrial biogenesis during stem cell differentiation

open access: yesAutophagy Reports, 2022
Differentiating stem cells must adapt their mitochondrial metabolism to fit the needs of the mature differentiated cell. In a recent study, we observed that during differentiation to an endothelial phenotype, pluripotent stem cell mitochondria are ...
Priyanka Gajwani, Jalees Rehman
doaj   +1 more source

Effects of Telmisartan, an AT1 receptor antagonist, on mitochondria-specific genes expression in a mouse MPTP model of Parkinsonism

open access: yesFrontiers in Bioscience-Landmark, 2021
Background: Mitochondrial dysfunction plays a crucial role in Parkinson’s disease (PD) pathogenesis. The present study was undertaken to investigate the effects of Telmisartan (TEL), an angiotensin II type 1 receptor (AT1R) blocker, on the mitochondria ...
Bipul Ray   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy